Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma

被引：1
|
作者：
Song, Yuxuan [1 ]
Peng, Yun [1 ]
Qin, Caipeng [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Urol, Beijing 100044, Peoples R China
来源：
WORLD JOURNAL OF UROLOGY | 2023年 / 41卷 / 08期
关键词：
CANCER;
D O I：
10.1007/s00345-023-04497-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [41] Progress and potential of immune checkpoint blockade for treating advanced renal cell carcinoma
    Tykodi, Scott S.
    IMMUNOTHERAPY, 2013, 5 (06) : 607 - 619
  • [42] Systematic review on the efficacy and safety of immune checkpoint inhibition in renal cell carcinoma
    Lyu, Chen
    Li, Wenyue
    Liu, Songcai
    Gao, Shuang
    Zhang, Hong
    Hao, Linlin
    Yu, Hao
    Wei, Wenzhen
    Song, Jie
    Yang, Yaoyao
    Wang, Chunmeng
    Zhang, Zhimin
    Wang, Nan
    FUTURE ONCOLOGY, 2018, 14 (21) : 2207 - 2221
  • [43] Perioperative Immune Checkpoint Inhibitors in Renal Cell and Urothelial Carcinomas: An Exciting New Paradigm under Investigation?
    Buonerba, Carlo
    Grivas, Petros
    Di Lorenzo, Giuseppe
    ONCOLOGY, 2021, 99 (11) : 681 - 685
  • [44] Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
    Bakouny, Ziad
    El Zarif, Talal
    Dudani, Shaan
    Wells, J. Connor
    Gan, Chun Loo
    Donskov, Frede
    Shapiro, Julia
    Davis, Ian D.
    Parnis, Francis
    Ravi, Praful
    Steinharter, John A.
    Agarwal, Neeraj
    Alva, Ajjai
    Wood, Lori
    Kapoor, Anil
    Morales, Jose M. Ruiz
    Kollmannsberger, Christian
    Beuselinck, Benoit
    Xie, Wanling
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    EUROPEAN UROLOGY, 2023, 83 (02) : 145 - 151
  • [45] Advanced CT Imaging, Radiomics, and Artificial Intelligence to Evaluate Immune Checkpoint Inhibitors' Effects on Metastatic Renal Cell Carcinoma
    Greco, Federico
    Beomonte Zobel, Bruno
    Di Gennaro, Gianfranco
    Mallio, Carlo Augusto
    APPLIED SCIENCES-BASEL, 2023, 13 (06):
  • [46] Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors
    Yildirim, Ahmet
    Wei, Mengting
    Liu, Yuan
    Nazha, Bassel
    Brown, Jacqueline T.
    Carthon, Bradley C.
    Choi, Yujin
    Suh, Lauren
    Goswamy, Rohit V.
    Mcclintock, Greta R.
    Hartman, Caitlin
    Caulfield, Sarah
    Ciuro, Jordan
    Goldman, Jamie M.
    Harris, Wayne B.
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [47] Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review
    Rebuzzi, Sara Elena
    Perrone, Fabiana
    Bersanelli, Melissa
    Bregni, Giacomo
    Milella, Michele
    Buti, Sebastiano
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (02) : 169 - 185
  • [48] First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
    Naito, Renato
    Izumi, Kouji
    Mizokami, Atsushi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 986 - 990
  • [49] A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
    Khaki, Ali Raza
    Li, Ang
    Diamantopoulos, Leonidas N.
    Miller, Natalie J.
    Carril-Ajuria, Lucia
    Castellano, Daniel
    De Kouchkovsky, Ivan
    Koshkin, Vadim
    Park, Joseph
    Alva, Ajjai
    Bilen, Mehmet A.
    Stewart, Tyler
    Santos, Victor
    Agarwal, Neeraj
    Jain, Jayanshu
    Zakharia, Yousef
    Morales-Barrera, Rafael
    Devitt, Michael
    Nelson, Ariel
    Hoimes, Christopher J.
    Shreck, Evan
    Gartrell, Benjamin A.
    Sankin, Alex
    Tripathi, Abhishek
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Rodriguez-Vida, Alejo
    Drakaki, Alexandra
    Liu, Sandy
    Kumar, Vivek
    Lythgoe, Mark P.
    Pinato, David J.
    Murgic, Jure
    Frobe, Ana
    Joshi, Monika
    Velho, Pedro Isaacsson
    Hahn, Noah
    Buznego, Lucia Alonso
    Duran, Ignacio
    Moses, Marcus
    Barata, Pedro
    Galsky, Matthew D.
    Sonpavde, Guru
    Yu, Evan Y.
    Shankaran, Veena
    Lyman, Gary H.
    Grivas, Petros
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 464 - 472
  • [50] Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
    Yao, Ji-Ming
    Zhong, Jia-Lei
    Zhou, Qiang
    Guo, Ju
    WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
12345